Global Blood-Grouping Reagents Market Report 2024-2028, Featuring AliveDX, Atlas Medical, BAG Health Care, Calibre Scientific, Novacyt, QuidelOrtho, Rapid Labs, Paragon Care and VitroScient
April 18, 2024 11:14 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Global Blood-Grouping Reagents Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The latest market analysis predicts...
Global Blood Management and Diagnostics Market Size to Reach USD 7.48 Billion in 2032 | Emergen Research
September 26, 2023 10:10 ET
|
Emergen Research
Vancouver, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global Blood Management and Diagnostics Market size was USD 4.40 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% during...
Blood Transfusion Diagnostics Market Hit $6.48Bn, Globally, by 2028 Growing at 6.9% CAGR, Says The Insight Partners
July 27, 2022 10:30 ET
|
The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Quotient Limited Announces CFO Transition
November 02, 2016 16:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
October 31, 2016 16:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
October 21, 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
October 17, 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited Announces $120 Million Secured Debt Financing
October 14, 2016 16:01 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
September 08, 2016 16:05 ET
|
Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
August 08, 2016 16:15 ET
|
Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...